Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CUL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GUCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6836 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GID8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC123 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMBIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3I - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCARB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on